Coffee Day Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:57 pm

Quick Insight

Coffee Day Enterprises Ltd's current market dynamics show a significant undervaluation with a share price of ₹35.3 and a market cap of ₹745 Cr., coupled with a low P/E ratio. The company's Return on Equity (ROE) and Return on Capital Employed (ROCE) at 0.89% and 1.13% respectively suggest operational inefficiencies. With a high debt level of ₹1,373 Cr. against reserves of ₹2,379 Cr., there are concerns about solvency. The low Price-to-Book Value ratio of 0.22x indicates a potential value opportunity for investors, although the negative net profit of -143 Cr. raises red flags. Overall, cautious optimism is warranted, pending a turnaround in operational performance and debt management strategies.

Competitors of Coffee Day Enterprises Ltd

All Competitor Stocks of Coffee Day Enterprises Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:28 am

Below is a detailed analysis of the quarterly data for Coffee Day Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 268.00 Cr.. The value appears to be declining and may need further review. It has decreased from 280.00 Cr. (Dec 2024) to 268.00 Cr., marking a decrease of 12.00 Cr..
• For Expenses, as of Mar 2025, the value is 240.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 244.00 Cr. (Dec 2024) to 240.00 Cr., marking a decrease of 4.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Dec 2024) to 28.00 Cr., marking a decrease of 8.00 Cr..
• For OPM %, as of Mar 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Dec 2024) to 10.00%, marking a decrease of 3.00%.
• For Other Income, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Dec 2024) to 60.00 Cr., marking an increase of 55.00 Cr..
• For Interest, as of Mar 2025, the value is 46.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.00 Cr. (Dec 2024) to 46.00 Cr., marking an increase of 25.00 Cr..
• For Depreciation, as of Mar 2025, the value is 28.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 32.00 Cr. (Dec 2024) to 28.00 Cr., marking a decrease of 4.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from -11.00 Cr. (Dec 2024) to 15.00 Cr., marking an increase of 26.00 Cr..
• For Tax %, as of Mar 2025, the value is 865.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Dec 2024) to 865.00%, marking an increase of 865.00%.
• For Net Profit, as of Mar 2025, the value is -114.00 Cr.. The value appears to be declining and may need further review. It has decreased from -11.00 Cr. (Dec 2024) to -114.00 Cr., marking a decrease of 103.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -1.56. The value appears to be declining and may need further review. It has decreased from -0.49 (Dec 2024) to -1.56, marking a decrease of 1.07.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:10 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:32 pm

Below is a detailed analysis of the balance sheet data for Coffee Day Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 211.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 211.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,379.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,645.00 Cr. (Mar 2024) to 2,379.00 Cr., marking a decrease of 266.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,373.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,363.00 Cr. (Mar 2024) to 1,373.00 Cr., marking an increase of 10.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 975.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 883.00 Cr. (Mar 2024) to 975.00 Cr., marking an increase of 92.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,939.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,103.00 Cr. (Mar 2024) to 4,939.00 Cr., marking a decrease of 164.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 516.00 Cr.. The value appears to be declining and may need further review. It has decreased from 553.00 Cr. (Mar 2024) to 516.00 Cr., marking a decrease of 37.00 Cr..
• For CWIP, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
• For Investments, as of Mar 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 35.00 Cr..
• For Other Assets, as of Mar 2025, the value is 4,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,499.00 Cr. (Mar 2024) to 4,336.00 Cr., marking a decrease of 163.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,939.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,103.00 Cr. (Mar 2024) to 4,939.00 Cr., marking a decrease of 164.00 Cr..

Notably, the Reserves (2,379.00 Cr.) exceed the Borrowings (1,373.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Coffee Day Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -2.75. This value is below the healthy minimum of 5. It has increased from -15.27 (Mar 24) to -2.75, marking an increase of 12.52.
• For Diluted EPS (Rs.), as of Mar 25, the value is -2.75. This value is below the healthy minimum of 5. It has increased from -15.27 (Mar 24) to -2.75, marking an increase of 12.52.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 3. It has increased from -8.28 (Mar 24) to -0.56, marking an increase of 7.72.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.63. It has decreased from 148.14 (Mar 24) to 122.63, marking a decrease of 25.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.63. It has decreased from 148.14 (Mar 24) to 122.63, marking a decrease of 25.51.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.02. It has increased from 47.96 (Mar 24) to 51.02, marking an increase of 3.06.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.57. This value is within the healthy range. It has decreased from 12.86 (Mar 24) to 8.57, marking a decrease of 4.29.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.64. This value is within the healthy range. It has decreased from 6.64 (Mar 24) to 2.64, marking a decrease of 4.00.
• For PBT / Share (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 0. It has increased from -17.42 (Mar 24) to -0.29, marking an increase of 17.13.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -6.50. This value is below the healthy minimum of 2. It has increased from -14.51 (Mar 24) to -6.50, marking an increase of 8.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -2.75. This value is below the healthy minimum of 2. It has increased from -15.27 (Mar 24) to -2.75, marking an increase of 12.52.
• For PBDIT Margin (%), as of Mar 25, the value is 16.80. This value is within the healthy range. It has decreased from 26.81 (Mar 24) to 16.80, marking a decrease of 10.01.
• For PBIT Margin (%), as of Mar 25, the value is 5.16. This value is below the healthy minimum of 10. It has decreased from 13.84 (Mar 24) to 5.16, marking a decrease of 8.68.
• For PBT Margin (%), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 10. It has increased from -36.31 (Mar 24) to -0.57, marking an increase of 35.74.
• For Net Profit Margin (%), as of Mar 25, the value is -12.74. This value is below the healthy minimum of 5. It has increased from -30.24 (Mar 24) to -12.74, marking an increase of 17.50.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -5.38. This value is below the healthy minimum of 8. It has increased from -31.82 (Mar 24) to -5.38, marking an increase of 26.44.
• For Return on Networth / Equity (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 15. It has increased from -11.28 (Mar 24) to -2.24, marking an increase of 9.04.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 10. It has decreased from 4.11 (Mar 24) to 1.66, marking a decrease of 2.45.
• For Return On Assets (%), as of Mar 25, the value is -1.17. This value is below the healthy minimum of 5. It has increased from -6.31 (Mar 24) to -1.17, marking an increase of 5.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 24) to 0.15, marking an increase of 0.12.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.40 (Mar 24) to 0.53, marking an increase of 0.13.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.21. It has increased from 0.18 (Mar 24) to 0.21, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.31, marking an increase of 0.14.
• For Quick Ratio (X), as of Mar 25, the value is 2.29. This value exceeds the healthy maximum of 2. It has increased from 2.15 (Mar 24) to 2.29, marking an increase of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.83. This value exceeds the healthy maximum of 8. It has increased from 13.57 (Mar 24) to 14.83, marking an increase of 1.26.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.65. This value is below the healthy minimum of 3. It has decreased from 9.17 (Mar 24) to 1.65, marking a decrease of 7.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.68. This value is below the healthy minimum of 3. It has decreased from 6.81 (Mar 24) to -0.68, marking a decrease of 7.49.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,072.32. It has decreased from 2,256.07 (Mar 24) to 2,072.32, marking a decrease of 183.75.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.92, marking a decrease of 0.31.
• For EV / EBITDA (X), as of Mar 25, the value is 11.44. This value is within the healthy range. It has increased from 8.30 (Mar 24) to 11.44, marking an increase of 3.14.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.54, marking a decrease of 0.50.
• For Price / BV (X), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 24) to 0.22, marking a decrease of 0.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.54, marking a decrease of 0.50.
• For EarningsYield, as of Mar 25, the value is -0.09. This value is below the healthy minimum of 5. It has increased from -0.30 (Mar 24) to -0.09, marking an increase of 0.21.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness